Charles Oh

Nerve growth factor: an update on the science and therapy

Importance of Side Effects in Opioid Treatment: A Trade-Off Analysis With Patients and Physicians

Parkinson's disease

OARSI guidelines for the non-surgical management of knee osteoarthritis

Factors affecting bacterial biofilm expression in chronic rhinosinusitis and the influences on prognosis

Long-term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain

Molecular basis of ancestral vertebrate electroreception

Osteoarthritis

Voltage-gated Ca2+ channel CaV1.3 subunit expressed in the hair cell epithelium of the sacculus of the trout Oncorhynchus mykiss: cloning and comparison across vertebrate classes

Osteoarthritis

RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH

Bacterial Biofilm and its Role in the Pathogenesis of Disease

Diagnosis and Treatment of Parkinson Disease

CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016

Bacterial Pattern in Chronic Sinusitis and Cystic Fibrosis

The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop

Clinical Practice Guideline (Update): Adult Sinusitis

CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016

Oral or transdermal opioids for osteoarthritis of the knee or hip

Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial

Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: A 10-day, phase III, randomized, double-blind, active- and placebo-controlled study

Selective expression of serotonin receptor transcripts in the mammalian cochlea and its subdivisions

Effects of Acetaminophen, Naproxen, and Acetylsalicylic Acid on Tapentadol Pharmacokinetics: Results of Two Randomized, Open‐Label, Crossover, Drug‐Drug Interaction Studies

Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in treatment of patients with moderate-to-severe osteoarthritis pain

Bacteriology in Patients with Chronic Sinusitis who have been Medically and Surgically Treated

Efficacy, safety, and tolerability of fulranumab in treatment of patients with moderate-to-severe, chronic low back pain

A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain